Selpercatinib in patients with RET fusion–positive non–small-cell lung cancer: Updated safety and efficacy from the registrational LIBRETTO-001 phase I/II trial Journal Article
| Authors: | Drilon, A.; Subbiah, V.; Gautschi, O.; Tomasini, P.; de Braud, F.; Solomon, B. J.; Shao-Weng Tan, D.; Alonso, G.; Wolf, J.; Park, K.; Goto, K.; Soldatenkova, V.; Szymczak, S.; Barker, S. S.; Puri, T.; Bence Lin, A.; Loong, H.; Besse, B. |
| Article Title: | Selpercatinib in patients with RET fusion–positive non–small-cell lung cancer: Updated safety and efficacy from the registrational LIBRETTO-001 phase I/II trial |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 2 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-01-10 |
| Start Page: | 385 |
| End Page: | 394 |
| Language: | English |
| DOI: | 10.1200/jco.22.00393 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PMCID: | PMC9839260 |
| PUBMED: | 36122315 |
| DOI/URL: | |
| Notes: | MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Alexander Drilon -- Accession Number: 161156224 -- Entry Date: In Process -- Revision Date: 20230109 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl |
